Asked by: Ruth Jones (Labour - Newport West and Islwyn)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the accuracy of data collected on all women at increased risk of breast cancer.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Disease Registration Service (NDRS) in NHS England provides England’s national resource for data and analytics on cancer, rare diseases, and congenital conditions.
The NDRS already serves as a national register for women at very high risk of breast cancer. NDRS curates and quality assures the collected data to ensure sufficient accuracy and completeness. The NDRS works closely with the very high risk National Breast Screening Programme to ensure safe and robust identification of women at very high risk of cancer. The integration of this data within the wider NDRS cancer data infrastructure maximises the use of this data which helps with service planning, evaluation, and improvement, and reduces the fragmentation and siloing that would occur with standalone registers.
Asked by: Fabian Hamilton (Labour - Leeds North East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the report published by Breast Cancer Now, entitled Setting the Bar too High, what assessment his Department has made of the impact of the opportunity cost‑neutrality requirement within NICE’s severity modifier on access to treatments for secondary breast cancer.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The severity modifier was introduced by the National Institute for Health and Care Excellence (NICE) in January 2022 as part of a number of changes intended to make its methods fairer, faster, and more consistent. The severity modifier was designed on the principle of opportunity cost neutrality to ensure that introducing additional weighting for severe conditions did not increase overall National Health Service spending or displace more care than the previous end-of-life modifier.
NICE has been monitoring how the severity modifier is being applied and found that it has resulted in a greater proportion of medicines recommended than under NICE’s previous methods. The latest figures indicate 87.0% of decisions taken since the severity modifier was implemented have recommended use of the treatment, compared with 82.5% when the end-of-life modifier was being used. For advanced cancer treatments specifically, 84.8% of decisions have been positive since the introduction of the severity modifier, compared to 69.1% under NICE’s previous methods.
Asked by: Liz Jarvis (Liberal Democrat - Eastleigh)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that patients with secondary breast cancer have a clinical nurse specialist allocated to them.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
In 2024/25, approximately 8,000 people received training to either enter the cancer and diagnostics workforce or to develop in their roles. As part of this, over 1,600 people were on apprenticeship courses, with over 270 additional medical specialty training places funded. Over 1,000 clinical nurse specialist grants were made available to new and aspiring clinical nurse specialists.
NHS England is also investing in structured career development and education support. The Aspirant Cancer Career and Education Development programme provides a nationally agreed framework for capability, career development, and education for nurses, allied health professionals, and the support workforce working in cancer care. This is also beneficial for the training and development of clinical nurse specialists working in breast cancer care.
Asked by: Mims Davies (Conservative - East Grinstead and Uckfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure a) all women who are eligible take up breast screening in West Sussex and b) his Department tracks and follows up on non-attendance appointments.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
All eligible individuals, including in East and West Sussex, are given a timed appointment to attend the screening location closest to their registered general practice address, with the option to change the appointment time or location given by contacting the service. Research has shown that timed appointments are more effective in encouraging attendance. The service sends text reminders two and seven days before appointments.
Should an individual not attend their appointment, they are automatically given a new timed appointment at the same location and the same text reminder process occurs. If the individual does not attend the second timed appointment, they are offered an open invitation. This means that the individual can contact the service to book their own appointment. Since implementation of text reminders, the service has seen an improvement in appointment attendance, in line with expectations based on research.
Regular “do not attend” audits are undertaken by the service. The processes involved with these audits help identify any common rationales for non-attendance that can inform service improvement strategies.
Asked by: Mims Davies (Conservative - East Grinstead and Uckfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) ensure all women who are eligible take up breast screening in East Sussex and (b) track and follow up on non-attendance appointments.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
All eligible individuals, including in East and West Sussex, are given a timed appointment to attend the screening location closest to their registered general practice address, with the option to change the appointment time or location given by contacting the service. Research has shown that timed appointments are more effective in encouraging attendance. The service sends text reminders two and seven days before appointments.
Should an individual not attend their appointment, they are automatically given a new timed appointment at the same location and the same text reminder process occurs. If the individual does not attend the second timed appointment, they are offered an open invitation. This means that the individual can contact the service to book their own appointment. Since implementation of text reminders, the service has seen an improvement in appointment attendance, in line with expectations based on research.
Regular “do not attend” audits are undertaken by the service. The processes involved with these audits help identify any common rationales for non-attendance that can inform service improvement strategies.
Asked by: Lord Kamall (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of regional variation in breast cancer screening uptake, particularly in areas where uptake is significantly below the national average.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
This Government is committed to improving the NHS Breast Screening Programme (NHS BSP) and addressing regional variation in uptake.
To improve uptake and address inequalities, this year, NHS England is planning to publish a Breast Screening Programme Uptake Improvement Review.
This will include a review of actions taken at a national level by the NHS BSP so far, as well as setting out where the focus will be going forward, to support local services to drive uptake even further.
The review supports breast screening service providers with national solutions such as:
In February 2025, NHS England launched the first ever National Health Service breast screening campaign nationally to widespread media attention. It ran across television, radio, social media, and outdoor advertising during February and March, targeting women of breast screening age, with a focus on those least likely to attend, including younger women, those in deprived areas, ethnic minorities, and disabled women.
Asked by: Grahame Morris (Labour - Easington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the additional number of people expected to be diagnosed with cancer as a result of increases in NHS cancer screening uptake in a) 2026, b) 2027 and c) 2028.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
As a Government, we are taking decisive action so that the National Health Service diagnoses cancer earlier and treats it faster.
Last year, we announced the introduction of self-test kits for under-screened women in the NHS Cervical Screening Programme. Under-screened women will receive home testing kits starting with those that are the most overdue for screening. This will help tackle deeply entrenched barriers that keep some away from life-saving screening.
In the NHS Bowel Cancer Screening Programme, a more sensitive threshold for the bowel screening faecal immunochemical test is being piloted, and if rolled out nationally could find 700 more colorectal cancers per year and 2,000 high risk polyps.
In February 2025, NHS England launched the first ever NHS breast screening campaign nationally to widespread media attention. It ran across television, radio, social media, and outdoor advertising, targeting women of breast screening age, with a focus on those least likely to attend, including younger women, those in deprived areas, ethnic minorities, and disabled women.
This Government is committed to focusing on early intervention and helping people to live longer, healthier lives. These initiatives, among others, mean we expect to identify more people who are living with cancer in 2026, 2027 and 2028, and catch those cancers earlier.
Asked by: Grahame Morris (Labour - Easington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has made an estimate of the number of people expected to be diagnosed with cancer as a result of NHS cancer screening programmes in a) 2026, b) 2027 and c) 2028.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
As a Government, we are taking decisive action so that the National Health Service diagnoses cancer earlier and treats it faster.
Last year, we announced the introduction of self-test kits for under-screened women in the NHS Cervical Screening Programme. Under-screened women will receive home testing kits starting with those that are the most overdue for screening. This will help tackle deeply entrenched barriers that keep some away from life-saving screening.
In the NHS Bowel Cancer Screening Programme, a more sensitive threshold for the bowel screening faecal immunochemical test is being piloted, and if rolled out nationally could find 700 more colorectal cancers per year and 2,000 high risk polyps.
In February 2025, NHS England launched the first ever NHS breast screening campaign nationally to widespread media attention. It ran across television, radio, social media, and outdoor advertising, targeting women of breast screening age, with a focus on those least likely to attend, including younger women, those in deprived areas, ethnic minorities, and disabled women.
This Government is committed to focusing on early intervention and helping people to live longer, healthier lives. These initiatives, among others, mean we expect to identify more people who are living with cancer in 2026, 2027 and 2028, and catch those cancers earlier.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps are being taken to improve the time taken for red flag referrals for breast cancer to be seen.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
It is a priority for the Government to support the National Health Service to diagnose cancer, including breast cancer, as early and quickly as possible, and to treat it faster, to improve outcomes for all patients across England.
The Department is responsible for healthcare in England and therefore has not made a formal assessment on the timescales for red flag referrals for breast cancer across the whole of the United Kingdom.
As the first step to ensuring early diagnosis and treatment in England, NHS England has delivered an extra 100,000 operations, scans, and appointments each week since the start of this administration. This is supported by an increase in capacity to meet the demand for diagnostic services through investment in new magnetic resonance imaging and computed tomography scanners.
The Department recognises that there is more to be done to ensure that patients have timely access to diagnosis, and remains committed to diagnosing all cancer types earlier, including breast cancer. To tackle late diagnoses, the NHS is implementing non-specific symptom pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type.
Reducing variation in cancer care in England, including the movement of patients through breast cancer care pathways, is a priority for the Government. To address this, NHS England funded audits into primary and metastatic breast cancer. Using routine data collected on patients diagnosed with breast cancer in an NHS setting, the audits bring together information to look at what is being done well, where it is being done well, and what needs to be done better. On 11 September 2025, the second State of the Nation report for primary and metastatic breast cancer was published by the National Cancer Audit Collaborating Centre, and officials in the Department and NHS England are acting on the findings where appropriate.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment has been made on the timescales for red flag referrals for breast cancer across the UK.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
It is a priority for the Government to support the National Health Service to diagnose cancer, including breast cancer, as early and quickly as possible, and to treat it faster, to improve outcomes for all patients across England.
The Department is responsible for healthcare in England and therefore has not made a formal assessment on the timescales for red flag referrals for breast cancer across the whole of the United Kingdom.
As the first step to ensuring early diagnosis and treatment in England, NHS England has delivered an extra 100,000 operations, scans, and appointments each week since the start of this administration. This is supported by an increase in capacity to meet the demand for diagnostic services through investment in new magnetic resonance imaging and computed tomography scanners.
The Department recognises that there is more to be done to ensure that patients have timely access to diagnosis, and remains committed to diagnosing all cancer types earlier, including breast cancer. To tackle late diagnoses, the NHS is implementing non-specific symptom pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type.
Reducing variation in cancer care in England, including the movement of patients through breast cancer care pathways, is a priority for the Government. To address this, NHS England funded audits into primary and metastatic breast cancer. Using routine data collected on patients diagnosed with breast cancer in an NHS setting, the audits bring together information to look at what is being done well, where it is being done well, and what needs to be done better. On 11 September 2025, the second State of the Nation report for primary and metastatic breast cancer was published by the National Cancer Audit Collaborating Centre, and officials in the Department and NHS England are acting on the findings where appropriate.